ArticleFrontiers in pharmacology2024

Analysis of adverse drug reactions of Denosumab (Prolia) in osteoporosis based on FDA adverse event reporting system (FAERS).

Ruibo Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.